1. Home
  2. FORD vs CNSP Comparison

FORD vs CNSP Comparison

Compare FORD & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FORD
  • CNSP
  • Stock Information
  • Founded
  • FORD 1961
  • CNSP 2017
  • Country
  • FORD United States
  • CNSP United States
  • Employees
  • FORD N/A
  • CNSP N/A
  • Industry
  • FORD Plastic Products
  • CNSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • FORD Industrials
  • CNSP Health Care
  • Exchange
  • FORD Nasdaq
  • CNSP Nasdaq
  • Market Cap
  • FORD 6.5M
  • CNSP 6.5M
  • IPO Year
  • FORD 1995
  • CNSP 2019
  • Fundamental
  • Price
  • FORD $5.05
  • CNSP $3.23
  • Analyst Decision
  • FORD
  • CNSP Strong Buy
  • Analyst Count
  • FORD 0
  • CNSP 1
  • Target Price
  • FORD N/A
  • CNSP $0.50
  • AVG Volume (30 Days)
  • FORD 17.1K
  • CNSP 45.4M
  • Earning Date
  • FORD 02-13-2025
  • CNSP 03-31-2025
  • Dividend Yield
  • FORD N/A
  • CNSP N/A
  • EPS Growth
  • FORD N/A
  • CNSP N/A
  • EPS
  • FORD N/A
  • CNSP N/A
  • Revenue
  • FORD $29,658,939.00
  • CNSP N/A
  • Revenue This Year
  • FORD N/A
  • CNSP N/A
  • Revenue Next Year
  • FORD N/A
  • CNSP N/A
  • P/E Ratio
  • FORD N/A
  • CNSP N/A
  • Revenue Growth
  • FORD N/A
  • CNSP N/A
  • 52 Week Low
  • FORD $3.10
  • CNSP $2.81
  • 52 Week High
  • FORD $8.29
  • CNSP $1,195.00
  • Technical
  • Relative Strength Index (RSI)
  • FORD 37.54
  • CNSP 35.22
  • Support Level
  • FORD $5.00
  • CNSP $4.60
  • Resistance Level
  • FORD $6.18
  • CNSP $9.50
  • Average True Range (ATR)
  • FORD 0.48
  • CNSP 0.94
  • MACD
  • FORD -0.19
  • CNSP -0.15
  • Stochastic Oscillator
  • FORD 2.51
  • CNSP 6.28

About FORD Forward Industries Inc.

Forward Industries Inc is a provider of carrying and protective solutions. The company designs and distributes product protection for handheld electronic devices. Forward Industries sells soft-sided carrying cases for blood glucose diagnostic kits and portable consumer electronic devices such as tablets, personal computers, barcode Scanners, GPS devices, and others. The company operates in two segments, the OEM distribution segment sources and distributes carrying cases and other accessories for medical monitoring and diagnostic kits and a variety of other portable electronic and non-electronic devices directly to OEMs; The design segment, provides a full spectrum of hardware and software product design and engineering services. The majority of revenue is generated from the Design segment.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: